VickJW
2021-11-23
Like and comment please
Why Are Qualigen Therapeutics Shares Surging During Premarket Tuesday?
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
7
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":875524965,"tweetId":"875524965","gmtCreate":1637672239293,"gmtModify":1637672239462,"author":{"id":3578439260866475,"idStr":"3578439260866475","authorId":3578439260866475,"authorIdStr":"3578439260866475","name":"VickJW","avatar":"https://static.tigerbbs.com/dc8189137ac06a254539a020b5b368b2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":25,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like and comment please</p></body></html>","htmlText":"<html><head></head><body><p>Like and comment please</p></body></html>","text":"Like and comment please","highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/875524965","repostId":1123172180,"repostType":4,"repost":{"id":"1123172180","pubTimestamp":1637672009,"share":"https://www.laohu8.com/m/news/1123172180?lang=&edition=full","pubTime":"2021-11-23 20:53","market":"us","language":"en","title":"Why Are Qualigen Therapeutics Shares Surging During Premarket Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=1123172180","media":"Benzinga","summary":"Qualigen Therapeutics Inc shares are trading higher after a Zack's Small Cap research note showed a ","content":"<ul>\n <li><b>Qualigen Therapeutics Inc</b> shares are trading higher after a Zack's Small Cap research note showed a $9 price target on the stock.</li>\n <li>The report is based on a probability-adjusted DCF model that considers potential future revenues from QN-247 and RAS-F.</li>\n <li>The Company is currently conducting IND-enabling studies for QN-247, targeted to treat acute myeloid leukemia, pancreatic cancer, or glioblastoma.</li>\n <li>Additionally, the Company's RAS-F program is a family of protein-protein interaction inhibitors that could be effective in cancers with RAS mutations.</li>\n <li>An IND for QN-247 is anticipated in 2H of 2022.</li>\n <li>As of September 30, 2021, Qualigen held approximately $12.3 million in cash and cash equivalents, sufficient capital to fund operations into late 2022.</li>\n <li>The report mentions that the sales of FastPack are starting to pick up and believes that trend will continue now that more individuals are heading back to the doctor for routine checkups.</li>\n <li>The FastPack System is a proprietary diagnostics platform that consists of a single-use, disposable foil packet which includes the FastPack reagent chemistry.</li>\n <li><b>Price Action:</b> QLGN shares are up 84.8% at $2.31 during the premarket session on the last check Tuesday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Are Qualigen Therapeutics Shares Surging During Premarket Tuesday?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Are Qualigen Therapeutics Shares Surging During Premarket Tuesday?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-23 20:53 GMT+8 <a href=https://www.benzinga.com/analyst-ratings/analyst-color/21/11/24244115/why-are-qualigen-therapeutics-shares-surging-during-premarket-tuesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Qualigen Therapeutics Inc shares are trading higher after a Zack's Small Cap research note showed a $9 price target on the stock.\nThe report is based on a probability-adjusted DCF model that considers...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/21/11/24244115/why-are-qualigen-therapeutics-shares-surging-during-premarket-tuesday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QLGN":"Qualigen Therapeutics, Inc."},"source_url":"https://www.benzinga.com/analyst-ratings/analyst-color/21/11/24244115/why-are-qualigen-therapeutics-shares-surging-during-premarket-tuesday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123172180","content_text":"Qualigen Therapeutics Inc shares are trading higher after a Zack's Small Cap research note showed a $9 price target on the stock.\nThe report is based on a probability-adjusted DCF model that considers potential future revenues from QN-247 and RAS-F.\nThe Company is currently conducting IND-enabling studies for QN-247, targeted to treat acute myeloid leukemia, pancreatic cancer, or glioblastoma.\nAdditionally, the Company's RAS-F program is a family of protein-protein interaction inhibitors that could be effective in cancers with RAS mutations.\nAn IND for QN-247 is anticipated in 2H of 2022.\nAs of September 30, 2021, Qualigen held approximately $12.3 million in cash and cash equivalents, sufficient capital to fund operations into late 2022.\nThe report mentions that the sales of FastPack are starting to pick up and believes that trend will continue now that more individuals are heading back to the doctor for routine checkups.\nThe FastPack System is a proprietary diagnostics platform that consists of a single-use, disposable foil packet which includes the FastPack reagent chemistry.\nPrice Action: QLGN shares are up 84.8% at $2.31 during the premarket session on the last check Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":323,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":20,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/875524965"}
精彩评论